	Neoadjuvant therapy
Patient
Breast cancer
Letrozole
Adjuvant therapy
Aromatase inhibitors
	chemotherapy
breast cancer
treatment
adverse events
tamoxifen
letrozole
recent report
recurrence
significant
effective
side effects
hormone-sensitive breast cancer
important
adjuvant
patients
tumors
trial
risk
women
benefits
AIs
detrimental effect
cases
recent data
breast cancer continuum
randomized
third-generation inhibitors
years
metastatic
patient awareness
clinical superiority
long-term survivorship
decision
MBC
combination
anastrozole
placebo
regimens
sexual health
individual
interest
events
show
opportunity
increase

